Many natural compounds have been shown to potentiated the anticancer activity of bortezomib in vitro as well in vivo (69, 70) therefore, we sought to determine whether SNG can increase the anticancer effects of BTZ in MM cells when used as a combination treatment. The gene discussed is CASC3; the disease is Miyoshi myopathy.